img

Global Animal Blood Plasma Products and Derivatives Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Animal Blood Plasma Products and Derivatives Market Research Report 2024

Animal blood plasma products and derivatives refer to plasma-based products used in various applications, including food processing, pharmaceuticals, and diagnostics.
According to Mr Accuracy reports new survey, global Animal Blood Plasma Products and Derivatives market is projected to reach US$ 1541.4 million in 2029, increasing from US$ 1134.5 million in 2022, with the CAGR of 4.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Animal Blood Plasma Products and Derivatives market research.
The market for animal blood plasma products and derivatives is driven by the growing demand for high-quality and protein-rich ingredients in food and nutrition products. The pharmaceutical and biotechnology industries also contribute to the market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Animal Blood Plasma Products and Derivatives market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Lake Immunogenics
Auckland BioSciences
Kraeber & Co. GmbH
Sigma-Aldrich
Thermo Fisher Scientific
Rocky Mountain Biologicals
LAMPIRE Biological Laboratories
Bovogen Biologicals
Proliant
ANZCO Foods
Segment by Type
Immunoglobulin
Fibrinogen
Serum Albumin
Fetal Bovine Serum

Segment by Application


Cell Culture Media
Food Industry
Pharmaceutical Industry
Sports Nutrition
Nutrition Supplements
Cosmetic Industry
Diagnostic Industry
Pet Food Industry

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Animal Blood Plasma Products and Derivatives report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Animal Blood Plasma Products and Derivatives Market Overview
1.1 Product Overview and Scope of Animal Blood Plasma Products and Derivatives
1.2 Animal Blood Plasma Products and Derivatives Segment by Type
1.2.1 Global Animal Blood Plasma Products and Derivatives Market Value Comparison by Type (2024-2034)
1.2.2 Immunoglobulin
1.2.3 Fibrinogen
1.2.4 Serum Albumin
1.2.5 Fetal Bovine Serum
1.3 Animal Blood Plasma Products and Derivatives Segment by Application
1.3.1 Global Animal Blood Plasma Products and Derivatives Market Value by Application: (2024-2034)
1.3.2 Cell Culture Media
1.3.3 Food Industry
1.3.4 Pharmaceutical Industry
1.3.5 Sports Nutrition
1.3.6 Nutrition Supplements
1.3.7 Cosmetic Industry
1.3.8 Diagnostic Industry
1.3.9 Pet Food Industry
1.4 Global Animal Blood Plasma Products and Derivatives Market Size Estimates and Forecasts
1.4.1 Global Animal Blood Plasma Products and Derivatives Revenue 2018-2029
1.4.2 Global Animal Blood Plasma Products and Derivatives Sales 2018-2029
1.4.3 Global Animal Blood Plasma Products and Derivatives Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Animal Blood Plasma Products and Derivatives Market Competition by Manufacturers
2.1 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Manufacturers (2018-2024)
2.2 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Animal Blood Plasma Products and Derivatives Average Price by Manufacturers (2018-2024)
2.4 Global Animal Blood Plasma Products and Derivatives Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Animal Blood Plasma Products and Derivatives, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Animal Blood Plasma Products and Derivatives, Product Type & Application
2.7 Animal Blood Plasma Products and Derivatives Market Competitive Situation and Trends
2.7.1 Animal Blood Plasma Products and Derivatives Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Animal Blood Plasma Products and Derivatives Players Market Share by Revenue
2.7.3 Global Animal Blood Plasma Products and Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Animal Blood Plasma Products and Derivatives Retrospective Market Scenario by Region
3.1 Global Animal Blood Plasma Products and Derivatives Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Animal Blood Plasma Products and Derivatives Global Animal Blood Plasma Products and Derivatives Sales by Region: 2018-2029
3.2.1 Global Animal Blood Plasma Products and Derivatives Sales by Region: 2018-2024
3.2.2 Global Animal Blood Plasma Products and Derivatives Sales by Region: 2024-2029
3.3 Global Animal Blood Plasma Products and Derivatives Global Animal Blood Plasma Products and Derivatives Revenue by Region: 2018-2029
3.3.1 Global Animal Blood Plasma Products and Derivatives Revenue by Region: 2018-2024
3.3.2 Global Animal Blood Plasma Products and Derivatives Revenue by Region: 2024-2029
3.4 North America Animal Blood Plasma Products and Derivatives Market Facts & Figures by Country
3.4.1 North America Animal Blood Plasma Products and Derivatives Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Animal Blood Plasma Products and Derivatives Sales by Country (2018-2029)
3.4.3 North America Animal Blood Plasma Products and Derivatives Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Animal Blood Plasma Products and Derivatives Market Facts & Figures by Country
3.5.1 Europe Animal Blood Plasma Products and Derivatives Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Animal Blood Plasma Products and Derivatives Sales by Country (2018-2029)
3.5.3 Europe Animal Blood Plasma Products and Derivatives Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Animal Blood Plasma Products and Derivatives Market Facts & Figures by Country
3.6.1 Asia Pacific Animal Blood Plasma Products and Derivatives Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Country (2018-2029)
3.6.3 Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Animal Blood Plasma Products and Derivatives Market Facts & Figures by Country
3.7.1 Latin America Animal Blood Plasma Products and Derivatives Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Animal Blood Plasma Products and Derivatives Sales by Country (2018-2029)
3.7.3 Latin America Animal Blood Plasma Products and Derivatives Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Animal Blood Plasma Products and Derivatives Market Facts & Figures by Country
3.8.1 Middle East and Africa Animal Blood Plasma Products and Derivatives Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Animal Blood Plasma Products and Derivatives Sales by Country (2018-2029)
3.8.3 Middle East and Africa Animal Blood Plasma Products and Derivatives Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Animal Blood Plasma Products and Derivatives Sales by Type (2018-2029)
4.1.1 Global Animal Blood Plasma Products and Derivatives Sales by Type (2018-2024)
4.1.2 Global Animal Blood Plasma Products and Derivatives Sales by Type (2024-2029)
4.1.3 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2018-2029)
4.2 Global Animal Blood Plasma Products and Derivatives Revenue by Type (2018-2029)
4.2.1 Global Animal Blood Plasma Products and Derivatives Revenue by Type (2018-2024)
4.2.2 Global Animal Blood Plasma Products and Derivatives Revenue by Type (2024-2029)
4.2.3 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2018-2029)
4.3 Global Animal Blood Plasma Products and Derivatives Price by Type (2018-2029)
5 Segment by Application
5.1 Global Animal Blood Plasma Products and Derivatives Sales by Application (2018-2029)
5.1.1 Global Animal Blood Plasma Products and Derivatives Sales by Application (2018-2024)
5.1.2 Global Animal Blood Plasma Products and Derivatives Sales by Application (2024-2029)
5.1.3 Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2018-2029)
5.2 Global Animal Blood Plasma Products and Derivatives Revenue by Application (2018-2029)
5.2.1 Global Animal Blood Plasma Products and Derivatives Revenue by Application (2018-2024)
5.2.2 Global Animal Blood Plasma Products and Derivatives Revenue by Application (2024-2029)
5.2.3 Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2018-2029)
5.3 Global Animal Blood Plasma Products and Derivatives Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Lake Immunogenics
6.1.1 Lake Immunogenics Corporation Information
6.1.2 Lake Immunogenics Description and Business Overview
6.1.3 Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Lake Immunogenics Animal Blood Plasma Products and Derivatives Product Portfolio
6.1.5 Lake Immunogenics Recent Developments/Updates
6.2 Auckland BioSciences
6.2.1 Auckland BioSciences Corporation Information
6.2.2 Auckland BioSciences Description and Business Overview
6.2.3 Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Auckland BioSciences Animal Blood Plasma Products and Derivatives Product Portfolio
6.2.5 Auckland BioSciences Recent Developments/Updates
6.3 Kraeber & Co. GmbH
6.3.1 Kraeber & Co. GmbH Corporation Information
6.3.2 Kraeber & Co. GmbH Description and Business Overview
6.3.3 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Product Portfolio
6.3.5 Kraeber & Co. GmbH Recent Developments/Updates
6.4 Sigma-Aldrich
6.4.1 Sigma-Aldrich Corporation Information
6.4.2 Sigma-Aldrich Description and Business Overview
6.4.3 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Sigma-Aldrich Animal Blood Plasma Products and Derivatives Product Portfolio
6.4.5 Sigma-Aldrich Recent Developments/Updates
6.5 Thermo Fisher Scientific
6.5.1 Thermo Fisher Scientific Corporation Information
6.5.2 Thermo Fisher Scientific Description and Business Overview
6.5.3 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Product Portfolio
6.5.5 Thermo Fisher Scientific Recent Developments/Updates
6.6 Rocky Mountain Biologicals
6.6.1 Rocky Mountain Biologicals Corporation Information
6.6.2 Rocky Mountain Biologicals Description and Business Overview
6.6.3 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio
6.6.5 Rocky Mountain Biologicals Recent Developments/Updates
6.7 LAMPIRE Biological Laboratories
6.6.1 LAMPIRE Biological Laboratories Corporation Information
6.6.2 LAMPIRE Biological Laboratories Description and Business Overview
6.6.3 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2018-2024)
6.4.4 LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Product Portfolio
6.7.5 LAMPIRE Biological Laboratories Recent Developments/Updates
6.8 Bovogen Biologicals
6.8.1 Bovogen Biologicals Corporation Information
6.8.2 Bovogen Biologicals Description and Business Overview
6.8.3 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Bovogen Biologicals Animal Blood Plasma Products and Derivatives Product Portfolio
6.8.5 Bovogen Biologicals Recent Developments/Updates
6.9 Proliant
6.9.1 Proliant Corporation Information
6.9.2 Proliant Description and Business Overview
6.9.3 Proliant Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Proliant Animal Blood Plasma Products and Derivatives Product Portfolio
6.9.5 Proliant Recent Developments/Updates
6.10 ANZCO Foods
6.10.1 ANZCO Foods Corporation Information
6.10.2 ANZCO Foods Description and Business Overview
6.10.3 ANZCO Foods Animal Blood Plasma Products and Derivatives Sales, Revenue and Gross Margin (2018-2024)
6.10.4 ANZCO Foods Animal Blood Plasma Products and Derivatives Product Portfolio
6.10.5 ANZCO Foods Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Animal Blood Plasma Products and Derivatives Industry Chain Analysis
7.2 Animal Blood Plasma Products and Derivatives Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Animal Blood Plasma Products and Derivatives Production Mode & Process
7.4 Animal Blood Plasma Products and Derivatives Sales and Marketing
7.4.1 Animal Blood Plasma Products and Derivatives Sales Channels
7.4.2 Animal Blood Plasma Products and Derivatives Distributors
7.5 Animal Blood Plasma Products and Derivatives Customers
8 Animal Blood Plasma Products and Derivatives Market Dynamics
8.1 Animal Blood Plasma Products and Derivatives Industry Trends
8.2 Animal Blood Plasma Products and Derivatives Market Drivers
8.3 Animal Blood Plasma Products and Derivatives Market Challenges
8.4 Animal Blood Plasma Products and Derivatives Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Animal Blood Plasma Products and Derivatives Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Animal Blood Plasma Products and Derivatives Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Animal Blood Plasma Products and Derivatives Market Competitive Situation by Manufacturers in 2022
Table 4. Global Animal Blood Plasma Products and Derivatives Sales (MT) of Key Manufacturers (2018-2024)
Table 5. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Animal Blood Plasma Products and Derivatives Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Animal Blood Plasma Products and Derivatives Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Animal Blood Plasma Products and Derivatives Average Price (USD/Kg) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Animal Blood Plasma Products and Derivatives, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Animal Blood Plasma Products and Derivatives, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Animal Blood Plasma Products and Derivatives, Product Type & Application
Table 12. Global Key Manufacturers of Animal Blood Plasma Products and Derivatives, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Animal Blood Plasma Products and Derivatives by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Blood Plasma Products and Derivatives as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Animal Blood Plasma Products and Derivatives Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Animal Blood Plasma Products and Derivatives Sales by Region (2018-2024) & (MT)
Table 18. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Region (2018-2024)
Table 19. Global Animal Blood Plasma Products and Derivatives Sales by Region (2024-2029) & (MT)
Table 20. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Region (2024-2029)
Table 21. Global Animal Blood Plasma Products and Derivatives Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Region (2018-2024)
Table 23. Global Animal Blood Plasma Products and Derivatives Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Region (2024-2029)
Table 25. North America Animal Blood Plasma Products and Derivatives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Animal Blood Plasma Products and Derivatives Sales by Country (2018-2024) & (MT)
Table 27. North America Animal Blood Plasma Products and Derivatives Sales by Country (2024-2029) & (MT)
Table 28. North America Animal Blood Plasma Products and Derivatives Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Animal Blood Plasma Products and Derivatives Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Animal Blood Plasma Products and Derivatives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Animal Blood Plasma Products and Derivatives Sales by Country (2018-2024) & (MT)
Table 32. Europe Animal Blood Plasma Products and Derivatives Sales by Country (2024-2029) & (MT)
Table 33. Europe Animal Blood Plasma Products and Derivatives Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Animal Blood Plasma Products and Derivatives Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Region (2018-2024) & (MT)
Table 37. Asia Pacific Animal Blood Plasma Products and Derivatives Sales by Region (2024-2029) & (MT)
Table 38. Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Animal Blood Plasma Products and Derivatives Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Animal Blood Plasma Products and Derivatives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Animal Blood Plasma Products and Derivatives Sales by Country (2018-2024) & (MT)
Table 42. Latin America Animal Blood Plasma Products and Derivatives Sales by Country (2024-2029) & (MT)
Table 43. Latin America Animal Blood Plasma Products and Derivatives Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Animal Blood Plasma Products and Derivatives Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Animal Blood Plasma Products and Derivatives Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Animal Blood Plasma Products and Derivatives Sales by Country (2018-2024) & (MT)
Table 47. Middle East & Africa Animal Blood Plasma Products and Derivatives Sales by Country (2024-2029) & (MT)
Table 48. Middle East & Africa Animal Blood Plasma Products and Derivatives Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Animal Blood Plasma Products and Derivatives Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Animal Blood Plasma Products and Derivatives Sales (MT) by Type (2018-2024)
Table 51. Global Animal Blood Plasma Products and Derivatives Sales (MT) by Type (2024-2029)
Table 52. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2018-2024)
Table 53. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Type (2024-2029)
Table 54. Global Animal Blood Plasma Products and Derivatives Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Animal Blood Plasma Products and Derivatives Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2018-2024)
Table 57. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Type (2024-2029)
Table 58. Global Animal Blood Plasma Products and Derivatives Price (USD/Kg) by Type (2018-2024)
Table 59. Global Animal Blood Plasma Products and Derivatives Price (USD/Kg) by Type (2024-2029)
Table 60. Global Animal Blood Plasma Products and Derivatives Sales (MT) by Application (2018-2024)
Table 61. Global Animal Blood Plasma Products and Derivatives Sales (MT) by Application (2024-2029)
Table 62. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2018-2024)
Table 63. Global Animal Blood Plasma Products and Derivatives Sales Market Share by Application (2024-2029)
Table 64. Global Animal Blood Plasma Products and Derivatives Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Animal Blood Plasma Products and Derivatives Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2018-2024)
Table 67. Global Animal Blood Plasma Products and Derivatives Revenue Market Share by Application (2024-2029)
Table 68. Global Animal Blood Plasma Products and Derivatives Price (USD/Kg) by Application (2018-2024)
Table 69. Global Animal Blood Plasma Products and Derivatives Price (USD/Kg) by Application (2024-2029)
Table 70. Lake Immunogenics Corporation Information
Table 71. Lake Immunogenics Description and Business Overview
Table 72. Lake Immunogenics Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 73. Lake Immunogenics Animal Blood Plasma Products and Derivatives Product
Table 74. Lake Immunogenics Recent Developments/Updates
Table 75. Auckland BioSciences Corporation Information
Table 76. Auckland BioSciences Description and Business Overview
Table 77. Auckland BioSciences Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 78. Auckland BioSciences Animal Blood Plasma Products and Derivatives Product
Table 79. Auckland BioSciences Recent Developments/Updates
Table 80. Kraeber & Co. GmbH Corporation Information
Table 81. Kraeber & Co. GmbH Description and Business Overview
Table 82. Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 83. Kraeber & Co. GmbH Animal Blood Plasma Products and Derivatives Product
Table 84. Kraeber & Co. GmbH Recent Developments/Updates
Table 85. Sigma-Aldrich Corporation Information
Table 86. Sigma-Aldrich Description and Business Overview
Table 87. Sigma-Aldrich Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 88. Sigma-Aldrich Animal Blood Plasma Products and Derivatives Product
Table 89. Sigma-Aldrich Recent Developments/Updates
Table 90. Thermo Fisher Scientific Corporation Information
Table 91. Thermo Fisher Scientific Description and Business Overview
Table 92. Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 93. Thermo Fisher Scientific Animal Blood Plasma Products and Derivatives Product
Table 94. Thermo Fisher Scientific Recent Developments/Updates
Table 95. Rocky Mountain Biologicals Corporation Information
Table 96. Rocky Mountain Biologicals Description and Business Overview
Table 97. Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 98. Rocky Mountain Biologicals Animal Blood Plasma Products and Derivatives Product
Table 99. Rocky Mountain Biologicals Recent Developments/Updates
Table 100. LAMPIRE Biological Laboratories Corporation Information
Table 101. LAMPIRE Biological Laboratories Description and Business Overview
Table 102. LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 103. LAMPIRE Biological Laboratories Animal Blood Plasma Products and Derivatives Product
Table 104. LAMPIRE Biological Laboratories Recent Developments/Updates
Table 105. Bovogen Biologicals Corporation Information
Table 106. Bovogen Biologicals Description and Business Overview
Table 107. Bovogen Biologicals Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 108. Bovogen Biologicals Animal Blood Plasma Products and Derivatives Product
Table 109. Bovogen Biologicals Recent Developments/Updates
Table 110. Proliant Corporation Information
Table 111. Proliant Description and Business Overview
Table 112. Proliant Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 113. Proliant Animal Blood Plasma Products and Derivatives Product
Table 114. Proliant Recent Developments/Updates
Table 115. ANZCO Foods Corporation Information
Table 116. ANZCO Foods Description and Business Overview
Table 117. ANZCO Foods Animal Blood Plasma Products and Derivatives Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2024)
Table 118. ANZCO Foods Animal Blood Plasma Products and Derivatives Product
Table 119. ANZCO Foods Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Animal Blood Plasma Products and Derivatives Distributors List
Table 123. Animal Blood Plasma Products and Derivatives Customers List
Table 124. Animal Blood Plasma Products and Derivatives Market Trends
Table 125. Animal Blood Plasma Products and Derivatives Market Drivers
Table 126. Animal Blood Plasma Products and Derivatives Market Challenges
Table 127. Animal Blood Plasma Products and Derivatives Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Animal Blood Plasma Products and Derivatives
Figure 2. Global Animal Blood Plasma Products and Derivatives Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Animal Blood Plasma Products and Derivatives Market Share by Type in 2022 & 2029
Figure 4. Immunoglobulin Product Picture
Figure 5. Fibrinogen Product Picture
Figure 6. Serum Albumin Product Picture
Figure 7. Fetal Bovine Serum Product Picture
Figure 8. Global Animal Blood Plasma Products and Derivatives Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Animal Blood Plasma Products and Derivatives Market Share by Application in 2022 & 2029
Figure 10. Cell Culture Media
Figure 11. Food Industry
Figure 12. Pharmaceutical Industry
Figure 13. Sports Nutrition
Figure 14. Nutrition Supplements
Figure 15. Cosmetic Industry
Figure 16. Diagnostic Industry
Figure 17. Pet Food Industry
Figure 18. Global Animal Blood Plasma Products and Derivatives Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Animal Blood Plasma Products and Derivatives Market Size (2018-2029) & (US$ Million)
Figure 20. Global Animal Blood Plasma Products and Derivatives Sales (2018-2029) & (MT)
Figure 21. Global Animal Blood Plasma Products and Derivatives Average Price (USD/Kg) & (2018-2029)
Figure 22. Animal Blood Plasma Products and Derivatives Report Years Considered
Figure 23. Animal Blood Plasma Products and Derivatives Sales Share by Manufacturers in 2022
Figure 24. Global Animal Blood Plasma Products and Derivatives Revenue Share by Manufacturers in 2022
Figure 25. The Global 5 and 10 Largest Animal Blood Plasma Products and Derivatives Players: Market Share by Revenue in 2022
Figure 26. Animal Blood Plasma Products and Derivatives Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 27. Global Animal Blood Plasma Products and Derivatives Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 28. North America Animal Blood Plasma Products and Derivatives Sales Market Share by Country (2018-2029)
Figure 29. North America Animal Blood Plasma Products and Derivatives Revenue Market Share by Country (2018-2029)
Figure 30. U.S. Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Canada Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Europe Animal Blood Plasma Products and Derivatives Sales Market Share by Country (2018-2029)
Figure 33. Europe Animal Blood Plasma Products and Derivatives Revenue Market Share by Country (2018-2029)
Figure 34. Germany Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. France Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. U.K. Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Italy Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Russia Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Asia Pacific Animal Blood Plasma Products and Derivatives Sales Market Share by Region (2018-2029)
Figure 40. Asia Pacific Animal Blood Plasma Products and Derivatives Revenue Market Share by Region (2018-2029)
Figure 41. China Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Japan Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. South Korea Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. India Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Australia Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Taiwan Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Indonesia Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Thailand Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Malaysia Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Philippines Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Latin America Animal Blood Plasma Products and Derivatives Sales Market Share by Country (2018-2029)
Figure 52. Latin America Animal Blood Plasma Products and Derivatives Revenue Market Share by Country (2018-2029)
Figure 53. Mexico Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Brazil Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Argentina Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Middle East & Africa Animal Blood Plasma Products and Derivatives Sales Market Share by Country (2018-2029)
Figure 57. Middle East & Africa Animal Blood Plasma Products and Derivatives Revenue Market Share by Country (2018-2029)
Figure 58. Turkey Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. U.A.E Animal Blood Plasma Products and Derivatives Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Sales Market Share of Animal Blood Plasma Products and Derivatives by Type (2018-2029)
Figure 62. Global Revenue Market Share of Animal Blood Plasma Products and Derivatives by Type (2018-2029)
Figure 63. Global Animal Blood Plasma Products and Derivatives Price (USD/Kg) by Type (2018-2029)
Figure 64. Global Sales Market Share of Animal Blood Plasma Products and Derivatives by Application (2018-2029)
Figure 65. Global Revenue Market Share of Animal Blood Plasma Products and Derivatives by Application (2018-2029)
Figure 66. Global Animal Blood Plasma Products and Derivatives Price (USD/Kg) by Application (2018-2029)
Figure 67. Animal Blood Plasma Products and Derivatives Value Chain
Figure 68. Animal Blood Plasma Products and Derivatives Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed